2002

Dec 19, 2002
Guidant Receives CE Mark Approval for the MULTI-LINK VISION Cobalt Chromium Coronary Stent System

Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has received...

Dec 17, 2002
Guidant Completes Enrollment in Clinical Trial to Study Carotid Artery Stenting as Alternative Treatment for High Surgical-Risk Patients

Study Will Evaluate Potential New Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Dec 11, 2002
Guidant Acquires Cardiac Intelligence Corporation

Strategic Acquisition will Enhance Company Initiative to Enable Remote, Wireless Monitoring of Heart Function in Patients with Implanted Devices Indianapolis, Ind. - Guidant Corporation (NYSE and...

Dec 6, 2002
Guidant Appoints Guido J. Neels Group Chairman, Office of the President

Neels to Direct Guidant''s Worldwide Sales and Distribution Operations Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 27, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Court of Appeals Denies Stay of Injunction; Cook to Move Forward with Appeal Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Show 5102550100 per page
Top